Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Joint analysis of the metabolomics and transcriptomics uncovers the dysregulated network and develops the diagnostic model of high-risk neuroblastoma

9 Oct 2023

Abstract excerpt

Abstract High-risk neuroblastoma (HR-NB) has a significantly lower survival rate compared to low- and intermediate-risk NB (LIR-NB) due to the lack of risk classification diagnostic models and effective therapeutic targets. The present study aims to characterize the differences between neuroblastomas with different risks through transcriptomic and metabolomic, and establish an early diagnostic model for risk...

Topics

Join the communities discussing this publication.

Cancer, Hypoxia, and Metabolism
Neuroblastoma Research and Treatments
Ubiquitin and proteasome pathways

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37813883
DOI: 10.1038/s41598-023-43988-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Joint analysis of the metabolomics and transcriptomics uncovers the dysregulated network and develops the diagnostic model of high-risk neuroblastomaPMID 37813883Read ↗

Joint metabolomics and transcriptomics analysis systematically reveal the impact of MYCN in neuroblastomaSemantic proximity Read ↗

Metabolism and Tumor Microenvironment-Associated Molecular Classification of NeuroblastomaSemantic proximity Read ↗

A prognostic metabolism-related gene signature associated with the tumor immune microenvironment in neuroblastomaSemantic proximity Read ↗

Combined analysis of RNA-sequence and microarray data reveals effective metabolism-based prognostic signature for neuroblastoma.Semantic proximity Read ↗

Amino Acid Metabolism Subtypes in Neuroblastoma Identifying Distinct Prognosis and Therapeutic Vulnerabilities.Semantic proximity Read ↗

Identification and Characterization of a Glucometabolic Prognostic Gene Signature in Neuroblastoma based on N6-methyladenosine Eraser ALKBH5Semantic proximity Read ↗

Metabolic targeting of neuroblastoma, an updateSemantic proximity Read ↗

Integration RNA bulk and single cell RNA sequencing to explore the change of BCAA metabolism-related immune microenvironment and construct prognostic signature in HNSCCSemantic proximity Read ↗

Identification of prognostic biomarkers in neuroblastoma using WGCNA and multi-omics analysisSemantic proximity Read ↗

Amino acid metabolism‐related gene expression‐based risk signature can better predict overall survival for gliomaSemantic proximity Read ↗

Comprehensive Analysis Between Ferroptosis-Related Gene Signatures and Neuroblastoma PrognosisSemantic proximity Read ↗

Integrated Analysis of Cancer Tissue and Vitreous Humor from Retinoblastoma Eyes Reveals Unique Tumor-Specific Metabolic and Cellular Pathways in Advanced and Non-Advanced TumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.